| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021276616 |
| P356 | DOI | 10.1007/S10620-010-1418-8 |
| P932 | PMC publication ID | 3059822 |
| P698 | PubMed publication ID | 20931284 |
| P5875 | ResearchGate publication ID | 47371277 |
| P50 | author | Toshimitsu Hamasaki | Q40812240 |
| Takashi Asahara | Q115726097 | ||
| Koji Nomoto | Q115726098 | ||
| Osamu Tasaki | Q115726104 | ||
| Yasuyuki Kuwagata | Q115726105 | ||
| P2093 | author name string | Hisashi Sugimoto | |
| Kentaro Shimizu | |||
| Hiroshi Ogura | |||
| Masami Morotomi | |||
| Miki Goto | |||
| Asako Matsushima | |||
| P2860 | cites work | Metagenomic analysis of the human distal gut microbiome | Q24633486 |
| Immunosenescence: emerging challenges for an ageing population | Q24655433 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Gut flora in health and disease | Q28209082 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Microbial influences in inflammatory bowel diseases | Q29614264 | ||
| Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
| Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods | Q33886195 | ||
| Enteric flora in health and disease | Q33993768 | ||
| Primary prevention of atopic asthma | Q34607879 | ||
| Microbiology of bacterial translocation in humans | Q35348835 | ||
| Intestinal bacteria and ageing | Q36797288 | ||
| Safety assessment of dairy microorganisms: the Enterococcus genus. | Q36949329 | ||
| Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients | Q37234016 | ||
| Fecal flora of man. V. communication: The fluctuation of the fecal flora of the healthy adult (author's transl) | Q40087812 | ||
| Colistin-oxolinic acid-blood agar: a new selective medium for streptococci | Q40217273 | ||
| Colonization resistance | Q40285153 | ||
| Improved medium for selective isolation and enumeration of Bifidobacterium. | Q40322924 | ||
| Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis | Q44880291 | ||
| Altered gut flora and environment in patients with severe SIRS. | Q46926205 | ||
| Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
| Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. | Q54748967 | ||
| American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis | Q68141412 | ||
| Changes in small-intestine permeability with aging | Q72467076 | ||
| P433 | issue | 4 | |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 1171-1177 | |
| P577 | publication date | 2010-10-08 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome | |
| P478 | volume | 56 |
| Q36142133 | Acute gastrointestinal injury in the intensive care unit: a retrospective study |
| Q64068565 | Alterations in the gut microbiota of patients with silica-induced pulmonary fibrosis |
| Q39526032 | Antibiotic-Induced Gut Microbiota Disruption Decreases TNF-α Release by Mononuclear Cells in Healthy Adults |
| Q64078780 | Challenge to the Intestinal Mucosa During Sepsis |
| Q46626203 | Clinical review: Probiotics in critical care |
| Q83943565 | Dangerous Disappearing Act: Commensal Gut Microbiota After Acute Severe Insults |
| Q53220696 | Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury |
| Q51164852 | Differences in the gut microbiota of healthy children and those with type 1 diabetes |
| Q36235947 | Disruption of the microbiota across multiple body sites in critically ill children |
| Q87695782 | Does Total Parenteral Nutrition Increase the Mortality of Patients with Severe Sepsis in the ICU? |
| Q34359414 | Dynamic alteration of the colonic microbiota in intestinal ischemia-reperfusion injury |
| Q64885760 | Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death. |
| Q49901841 | Effects of Rhubarb on Intestinal Dysmotility in Critically Ill Patients |
| Q37514742 | Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease |
| Q36816915 | Gut Microbiome: What We Do and Don't Know |
| Q39044807 | Gut microbiome, surgical complications and probiotics |
| Q99630590 | Impact of fecal short-chain fatty acids on prognosis in critically ill patients |
| Q98177933 | Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit |
| Q40076639 | Infectious Endocarditis from Enterococcus faecalis Associated with Tubular Adenoma of the Sigmoid Colon |
| Q92857451 | Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis |
| Q52579155 | Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy |
| Q35665410 | Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis |
| Q64260282 | Letter on "Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial" |
| Q42819277 | Lipopolysaccharides Reduce Adipogenesis in 3T3-L1 Adipocytes Through Activation of NF-κB Pathway and Downregulation of AMPK Expression |
| Q37053023 | Markers of inflammation and coagulation may be modulated by enteral feeding strategy |
| Q34237727 | Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness |
| Q36922472 | Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients |
| Q43236528 | Microbiome as mediator: Do systemic infections start in the gut? |
| Q58689785 | Mucosal Immunity and the Intestinal Microbiome in the Development of Critical Illness |
| Q52656992 | Mycotoxin: Its Impact on Gut Health and Microbiota |
| Q35696770 | Neutrophil gelatinase-associated lipocalin regulates gut microbiota of mice. |
| Q34641213 | Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? |
| Q38042641 | Nutrient Signaling: Evolutionary Origins of the Immune-Modulating Effects of Dietary Fat |
| Q89220136 | Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection |
| Q35881062 | Persistent hyperglycemia modulates gut immune function and microbiota in rats. |
| Q26850446 | Probiotic/Synbiotic Therapy for Treating Critically Ill Patients from a Gut Microbiota Perspective |
| Q35079014 | Proceedings of the 2013 A.S.P.E.N. Research workshop: the interface between nutrition and the gut microbiome: implications and applications for human health [corrected]. |
| Q42194000 | Protective effects of bifidobacterial adhesin on intestinal mucosa of stressed male rats via modulation of inflammation |
| Q43744909 | Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome |
| Q90689891 | Rapid gastrointestinal loss of Clostridial Clusters IV and XIVa in the ICU associates with an expansion of gut pathogens |
| Q55187063 | Rectal and Naris Swabs: Practical and Informative Samples for Analyzing the Microbiota of Critically Ill Patients. |
| Q27021300 | Redefining the gut as the motor of critical illness |
| Q47599691 | Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure |
| Q30416024 | Selective digestive tract decontamination in critically ill patients |
| Q42262411 | Sepsis-associated Cholestasis in Adult Patients: A Prospective Study |
| Q59128544 | Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial |
| Q36942337 | TGF-β1 improves mucosal IgA dysfunction and dysbiosis following intestinal ischaemia-reperfusion in mice |
| Q113240435 | The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia |
| Q89627106 | The Gut Microbiome Distinguishes Mortality in Trauma Patients Upon Admission to the Emergency Department |
| Q28274385 | The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness |
| Q91816299 | The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition |
| Q36923723 | The Microbiome in Critical Illness: Firm Conclusions or Bact to Square One? |
| Q35919596 | The Shift of an Intestinal "Microbiome" to a "Pathobiome" Governs the Course and Outcome of Sepsis Following Surgical Injury |
| Q36331146 | The endogenous bacteria alter gut epithelial apoptosis and decrease mortality following Pseudomonas aeruginosa pneumonia |
| Q96123011 | The gut microbiome's role in the development, maintenance, and outcomes of sepsis |
| Q36161048 | The gut microbiota and gastrointestinal surgery |
| Q30248605 | The intestinal microbiome and surgical disease. |
| Q38085925 | The intestinal microbiota and host immune interactions in the critically ill |
| Q36575777 | The microbiome and critical illness |
| Q39238517 | The role of the gut microbiota in sepsis |
| Q90599913 | Therapeutic Potential of the Gut Microbiota in the Management of Sepsis |
| Q91827136 | Usage of Probiotics and its Clinical Significance at Surgically Treated Patients Sufferig from Colorectal Carcinoma |
Search more.